Sunday, July 8, 2018  

1:30 – 7:00 p.m. Registration and Partnering Help Desk Open – (Harbourfront Foyer)

3:00 – 5:00 p.m. Partnering Program – (Tilly-Tupper Room)

7:00 p.m. Public Lecture: (Sir John A. Ballroom)

• Martha Carlin – The Biocollective (USA)
• Emeran Mayer, MD, University of California, Los Angeles (UCLA) (USA)

Monday, July 9, 2018

7:30 a.m. – 5:00 p.m. Registration & Partnering Help Desk Open

7:30 – 8:15 a.m. Breakfast & Networking – (Archibald-Campbell Room)

8:15 a.m. Opening Remarks – (Archibald-Campbell Room)

8:30 – 9:00 a.m. Keynote Speaker

• John Cryan, PhD, University College, Cork (Ireland)
  The Microbiome: A Key Regulator of Neurodevelopment & Behaviour

9:00 – 10:00 a.m. SESSION 1: (Archibald-Campbell Room)

• Emeran Mayer, MD, University of California, Los Angeles, UCLA (USA)
  Role of the Brain-Gut Microbiome Axis in Obesity

10:00 – 10:30 a.m. Networking Break

10:30 a.m. – 12:00 p.m. SESSION 2:   INDUSTRY SPOTLIGHT PRESENTATIONS 

• Caroline Popper, MD, MPH – Diversigen (USA)
• Brian Klein, PhD – Vedanta Biosciences (USA)
• Phillip Strandwitz, PhD – Holobiome (USA)
• Amy Pooler, PhD – Nestle Institute of Health Sciences (Switzerland)

12:00 – 1:00 p.m. Lunch – (Harbourfront Foyer)

1:00 – 2:30 p.m. Partnering Program – (Tilly-Tupper Room)

2:30 – 4:00 p.m. SESSION 3 – (Archibald-Campbell Room)

• Filip Scheperjans, PhD/MD, Helsinki University (Finland)
  The Microbiome in Parkinson’s Disease: Role as a Potential Biomarker and Relation to Disease Progression
• Sangram Sisodia, PhD, University of Chicago (USA)
  Modulation of Amyloid Deposition and Neuroinflammation By the Microbiome
• Jun Sun, PhD, University of Illinois at Chicago (USA)
  A Gut Feeling in ALS (amyotrophic lateral sclerosis)

 4:00 – 4:15 p.m. Networking Break

4:15 – 5:15 p.m. SESSION 4 

• Silke Cresswell, MD, University of British Columbia (Canada)
  The Many Talents of Microbes and their Implications for Clinical Research in Parkinson’s Disease
  
• PANEL DISCUSSION – THE IMPACT OF MICROBIOME ON CLINICAL TRIAL OUTCOMES
  • Phillip Strandwitz, PhD – Holobiome (USA)
  • Natalia Palacios, PhD – University of Massachusetts, Lowell (USA)
  • Caroline Popper, MD, MPH – Diversigen (USA)
  • Denise Kelly, PhD, Seventure Partners (France)

6:00 p.m. Bus departs Delta Prince Edward Hotel to Lobster Dinner

6:30 p.m. Lobster Dinner & Social – New Glasgow Lobster Suppers (Bus transportation provided)

Tuesday, July 10, 2018

7:30 a.m. -3:30 pm. – Registration & Partnering Help Desk Open – (Harbourfront Foyer)

7:30 – 8:00 a.m. Breakfast & Networking (Harbourfront Foyer)

8:00 – 8:30 a.m Keynote Speaker (Industry) (Archibald-Campbell Room)

8:30 – 10:00 a.m SESSION 5:    INDUSTRY SPOTLIGHT PRESENTATIONS 

• Stewart Campbell, PhD – Axial Biotherapeutics (Canada)
• Martha Carlin – The BioCollective (USA)
• Jackalina VanKampen – Neurodyn (Canada)

10:00 – 10:30 a.m. Networking Break

10:30 – 12:00 p.m. SESSION 6: (Archibald-Campbell Room)

• Premysl Bercik, MD/PhD, McMaster University (Canada)
  Microbiota-Gut-Brain Axis: From Gut Dysfunction to Anxiety and Depression
• Lisa Brenner, PhD, VA Rocky Mountain Mental Illness Research Education and Clinical Center (MIRECC) (USA)
  Exploring Novel Strategies to Address Deployment-related injuries among Military Veterans
• Melanie Gareau, PhD, University of California Davis (USA)
  Microbes and Memories – How the Microbiota Can Impact Cognitive Function

12:00 – 1:00 p.m. Lunch – (Harbourfront Foyer)

1:00 – 2:30 p.m. Partnering Program – (Tilly-Tupper Room)

2:30 – 3:30 p.m SESSION 7: (Archibald-Campbell Room)

• Philip Strandwitz, PhD, Holobiome (USA)
  Modulation of Neurotransmitters and Neurotransmission by the Gut Microbiota
• Madelyn Houser, PhD Candidate, Emory University (USA)
  The Gut-brain Axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?

3:30 – 4:30 p.m. SESSION 8 – GUT FEEL – FUTURE DIRECTIONS

• Jackalina VanKampen – Neurodyn

4:30 p.m. Closing Remarks

Wine & Cheese Reception – (Tilly-Tupper Room)